GERN – Geron Corporation
Geron CorporationGERN
$1.12Name : Geron Corporation
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $718,503,488.00
EPSttm : -0.11
Geron Corporation
$1.12
0.88%$0.01
GERN — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
11.18
Margin Of Safety %
Put/Call OI Ratio
0.38
EPS Next Q Diff
0.01
EPS Last/This Y
0.11
EPS This/Next Y
Price
1.12
Target Price
3.4
Analyst Recom
2
Performance Q
-31.29
Upside
-412.5%
Beta
0.63
Ticker: GERN
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-05-11 | GERN | 1.39 | 0.44 | 0.03 | 52960 |
| 2026-05-12 | GERN | 1.4 | 0.44 | 0.15 | 53354 |
| 2026-05-13 | GERN | 1.415 | 0.44 | 0.01 | 53194 |
| 2026-05-14 | GERN | 1.405 | 0.44 | 0.18 | 53339 |
| 2026-05-15 | GERN | 1.295 | 0.44 | 0.16 | 53549 |
| 2026-05-18 | GERN | 1.235 | 0.44 | 0.03 | 51166 |
| 2026-05-19 | GERN | 1.25 | 0.43 | 0.04 | 51596 |
| 2026-05-20 | GERN | 1.26 | 0.43 | 0.02 | 51334 |
| 2026-05-21 | GERN | 1.265 | 0.43 | 0.00 | 51679 |
| 2026-05-22 | GERN | 1.285 | 0.42 | 0.30 | 52821 |
| 2026-05-26 | GERN | 1.295 | 0.42 | 0.01 | 52956 |
| 2026-05-27 | GERN | 1.265 | 0.42 | 0.15 | 52901 |
| 2026-05-28 | GERN | 1.25 | 0.42 | 0.04 | 52969 |
| 2026-05-29 | GERN | 1.24 | 0.42 | 0.45 | 53110 |
| 2026-06-02 | GERN | 1.165 | 0.42 | 0.15 | 53527 |
| 2026-06-03 | GERN | 1.155 | 0.41 | 0.09 | 54501 |
| 2026-06-04 | GERN | 1.2 | 0.40 | 0.34 | 55770 |
| 2026-06-05 | GERN | 1.175 | 0.40 | 0.06 | 56811 |
| 2026-06-08 | GERN | 1.125 | 0.40 | 0.18 | 56879 |
| 2026-06-09 | GERN | 1.11 | 0.38 | 0.01 | 56125 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-05-11 | GERN | 1.39 | 50.0 | 35.8 | -0.02 |
| 2026-05-12 | GERN | 1.40 | 50.0 | 35.8 | -0.02 |
| 2026-05-13 | GERN | 1.42 | 50.0 | 35.8 | -0.02 |
| 2026-05-14 | GERN | 1.40 | 50.0 | 35.8 | -0.02 |
| 2026-05-15 | GERN | 1.29 | 50.0 | 35.8 | -0.02 |
| 2026-05-18 | GERN | 1.24 | - | 35.8 | -0.02 |
| 2026-05-19 | GERN | 1.23 | - | 35.8 | -0.02 |
| 2026-05-20 | GERN | 1.26 | - | 35.8 | -0.02 |
| 2026-05-21 | GERN | 1.26 | - | 35.8 | -0.02 |
| 2026-05-22 | GERN | 1.28 | - | 35.8 | -0.02 |
| 2026-05-26 | GERN | 1.29 | - | 35.8 | -0.02 |
| 2026-05-27 | GERN | 1.26 | - | 35.8 | -0.02 |
| 2026-05-28 | GERN | 1.25 | - | 35.8 | -0.02 |
| 2026-05-29 | GERN | 1.24 | - | 35.8 | -0.02 |
| 2026-06-01 | GERN | 1.22 | - | 35.8 | -0.02 |
| 2026-06-02 | GERN | 1.16 | - | 35.8 | -0.02 |
| 2026-06-03 | GERN | 1.15 | - | 35.8 | -0.02 |
| 2026-06-04 | GERN | 1.20 | - | 35.8 | -0.02 |
| 2026-06-05 | GERN | 1.17 | - | 35.8 | -0.02 |
| 2026-06-08 | GERN | 1.12 | - | 35.8 | -0.02 |
| 2026-06-09 | GERN | 1.12 | - | 35.8 | -0.02 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-05-11 | GERN | -0.03 | -5.22 | 13.49 |
| 2026-05-12 | GERN | -0.03 | -5.22 | 12.43 |
| 2026-05-13 | GERN | -0.03 | -5.22 | 12.43 |
| 2026-05-14 | GERN | -0.03 | -5.22 | 12.43 |
| 2026-05-15 | GERN | -0.03 | -5.22 | 12.43 |
| 2026-05-18 | GERN | -0.03 | -5.23 | 12.43 |
| 2026-05-19 | GERN | -0.03 | -5.23 | 12.43 |
| 2026-05-20 | GERN | -0.03 | -5.23 | 12.43 |
| 2026-05-21 | GERN | -0.03 | -5.23 | 12.06 |
| 2026-05-22 | GERN | -0.07 | -5.23 | 12.06 |
| 2026-05-26 | GERN | -0.07 | -0.68 | 12.06 |
| 2026-05-27 | GERN | -0.07 | -0.68 | 12.06 |
| 2026-05-28 | GERN | -0.07 | -0.68 | 11.18 |
| 2026-05-29 | GERN | -0.07 | -0.68 | 11.18 |
| 2026-06-02 | GERN | -0.07 | -0.63 | 11.18 |
| 2026-06-03 | GERN | -0.07 | -0.63 | 11.18 |
| 2026-06-04 | GERN | -0.07 | -0.63 | 11.18 |
| 2026-06-05 | GERN | -0.07 | -0.63 | 11.18 |
| 2026-06-08 | GERN | -0.07 | -0.60 | 11.18 |
| 2026-06-09 | GERN | -0.07 | -0.60 | 11.18 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.01
Avg. EPS Est. Current Quarter
-0.01
Avg. EPS Est. Next Quarter
-0.01
Insider Transactions
-0.07
Institutional Transactions
-0.6
Beta
0.63
Average Sales Estimate Current Quarter
55
Average Sales Estimate Next Quarter
59
Fair Value
Quality Score
50
Growth Score
49
Sentiment Score
29
Actual DrawDown %
79.1
Max Drawdown 5-Year %
-79
Target Price
3.4
P/E
Forward P/E
17.23
PEG
P/S
3.66
P/B
3.13
P/Free Cash Flow
EPS
-0.1
Average EPS Est. Cur. Y
-0.02
EPS Next Y. (Est.)
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-35.48
Relative Volume
0.82
Return on Equity vs Sector %
-56.9
Return on Equity vs Industry %
-40.7
EPS 1 7Days Diff
EPS 1 30Days Diff
0.02
EBIT Estimation
35.8
◆
GERN
Healthcare
$1.12
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
28.8
Range 1M
4.3%
Sup Dist
1.5%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
82.1%
EPS NY
378.6%
52W%
8.8%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+132.2% upside
Upside
+132.2%
Quality
50
Geron CorporationSector: Healthcare
Industry: Biotechnology
Employees: 258
Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. The company's product pipeline includes RYTELO, a telomerase inhibitor for the treatment of adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia; IMerge which is in Phase 3 clinical trial for the treatment of lower-risk myelodysplastic syndromes; IMpactMF that is in Phase 3 for the treatment of relapsed/refractory myelofibrosis; Impress which is in Phase 2 clinical trial to treat higher risk myelodysplastic syndromes and acute myeloid leukemia (AML); IMproveMF which is in Phase 1 clinical trial for the treatment of frontline myelofibrosis; and IMAGINE which is in phase 1/2 clinical trial for the treatment of relapsed/refractory AML. Geron Corporation was incorporated in 1990 and is headquartered in Foster City, California.
GERN
Latest News
—
Caricamento notizie per GERN…
stock quote shares GERN – Geron Corporation Stock Price stock today
news today GERN – Geron Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch GERN – Geron Corporation yahoo finance google finance
stock history GERN – Geron Corporation invest stock market
stock prices GERN premarket after hours
ticker GERN fair value insiders trading